Report Overview:
The Global Facial Injectable Market achieved a valuation of $4.37 Billion in 2022 and is anticipated to exceed $8.82 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 9.2% during the forecast period from 2024 to 2032.
Key Market Players:
Ipsen, Merz Pharma, Suneva Medical Inc., Medytox Inc., Sinclair Pharma, Bloomage BioTechnology...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)